Candace Hillary Feldman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 50 | 2024 | 2156 | 8.310 |
Why?
|
Rheumatic Diseases | 19 | 2024 | 657 | 6.350 |
Why?
|
Rheumatology | 18 | 2024 | 620 | 4.650 |
Why?
|
Lupus Nephritis | 12 | 2024 | 323 | 2.960 |
Why?
|
Antirheumatic Agents | 12 | 2022 | 1380 | 2.640 |
Why?
|
Medicaid | 23 | 2022 | 2835 | 2.220 |
Why?
|
Hydroxychloroquine | 11 | 2023 | 429 | 2.100 |
Why?
|
Insurance Benefits | 4 | 2021 | 186 | 1.850 |
Why?
|
Medication Adherence | 10 | 2022 | 2190 | 1.840 |
Why?
|
Healthcare Disparities | 12 | 2024 | 3407 | 1.740 |
Why?
|
Azathioprine | 4 | 2021 | 354 | 1.270 |
Why?
|
Mycophenolic Acid | 4 | 2021 | 349 | 1.220 |
Why?
|
Immunosuppressive Agents | 10 | 2024 | 4213 | 1.210 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 598 | 1.130 |
Why?
|
Patient Acceptance of Health Care | 7 | 2024 | 3230 | 1.040 |
Why?
|
Medically Underserved Area | 2 | 2020 | 267 | 0.920 |
Why?
|
Vaccines | 2 | 2024 | 840 | 0.900 |
Why?
|
Vaccination | 4 | 2023 | 3431 | 0.830 |
Why?
|
International Classification of Diseases | 2 | 2024 | 934 | 0.730 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2021 | 104 | 0.690 |
Why?
|
Ambulatory Care | 2 | 2021 | 2778 | 0.680 |
Why?
|
Health Status Disparities | 2 | 2020 | 1878 | 0.610 |
Why?
|
Family Planning Services | 1 | 2021 | 277 | 0.610 |
Why?
|
Information Dissemination | 2 | 2024 | 1142 | 0.600 |
Why?
|
Papillomavirus Vaccines | 2 | 2015 | 495 | 0.600 |
Why?
|
Kidney Failure, Chronic | 4 | 2022 | 2504 | 0.600 |
Why?
|
Arthritis, Rheumatoid | 3 | 2022 | 3743 | 0.590 |
Why?
|
Contraception | 1 | 2021 | 360 | 0.590 |
Why?
|
Opportunistic Infections | 1 | 2021 | 376 | 0.580 |
Why?
|
Community Networks | 1 | 2019 | 202 | 0.580 |
Why?
|
Medicare | 5 | 2024 | 6820 | 0.570 |
Why?
|
Neutrophil Activation | 5 | 2013 | 180 | 0.570 |
Why?
|
United States | 39 | 2024 | 72920 | 0.550 |
Why?
|
Glucocorticoids | 5 | 2023 | 2156 | 0.550 |
Why?
|
Humans | 114 | 2024 | 766117 | 0.510 |
Why?
|
Hot Temperature | 1 | 2022 | 1440 | 0.510 |
Why?
|
Health Services Accessibility | 4 | 2024 | 5510 | 0.510 |
Why?
|
Cyclophosphamide | 3 | 2021 | 2232 | 0.500 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2019 | 300 | 0.490 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 949 | 0.490 |
Why?
|
Adult | 62 | 2024 | 223139 | 0.490 |
Why?
|
Awareness | 1 | 2019 | 653 | 0.490 |
Why?
|
Communicable Disease Control | 1 | 2021 | 856 | 0.470 |
Why?
|
Gout | 1 | 2021 | 622 | 0.460 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2021 | 4054 | 0.450 |
Why?
|
Patient Care | 1 | 2020 | 630 | 0.450 |
Why?
|
Infertility | 1 | 2021 | 655 | 0.450 |
Why?
|
Vulnerable Populations | 1 | 2019 | 717 | 0.440 |
Why?
|
Middle Aged | 48 | 2024 | 223083 | 0.420 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2016 | 391 | 0.410 |
Why?
|
Patient Selection | 2 | 2022 | 4249 | 0.410 |
Why?
|
Physician Executives | 1 | 2013 | 140 | 0.400 |
Why?
|
Female | 66 | 2024 | 396233 | 0.400 |
Why?
|
Chicago | 2 | 2024 | 255 | 0.400 |
Why?
|
Qualitative Research | 7 | 2024 | 3138 | 0.400 |
Why?
|
Aged | 33 | 2024 | 171219 | 0.390 |
Why?
|
Urban Health Services | 1 | 2012 | 176 | 0.380 |
Why?
|
Referral and Consultation | 1 | 2024 | 3617 | 0.370 |
Why?
|
Catastrophization | 1 | 2015 | 352 | 0.370 |
Why?
|
Neutrophils | 9 | 2013 | 3771 | 0.370 |
Why?
|
Young Adult | 24 | 2024 | 59868 | 0.350 |
Why?
|
Male | 54 | 2024 | 363935 | 0.340 |
Why?
|
Social Class | 2 | 2019 | 2007 | 0.340 |
Why?
|
Community Health Centers | 1 | 2013 | 469 | 0.330 |
Why?
|
Algorithms | 4 | 2024 | 14066 | 0.330 |
Why?
|
Health Resources | 1 | 2015 | 951 | 0.320 |
Why?
|
Residence Characteristics | 1 | 2019 | 2116 | 0.320 |
Why?
|
Hospitalization | 10 | 2022 | 10811 | 0.320 |
Why?
|
Quality Improvement | 1 | 2024 | 3849 | 0.320 |
Why?
|
Massachusetts | 4 | 2024 | 8882 | 0.310 |
Why?
|
Risk Factors | 23 | 2024 | 74857 | 0.300 |
Why?
|
Boston | 4 | 2024 | 9335 | 0.300 |
Why?
|
Renal Dialysis | 2 | 2022 | 1791 | 0.290 |
Why?
|
Adolescent | 26 | 2022 | 88819 | 0.290 |
Why?
|
Politics | 1 | 2014 | 821 | 0.290 |
Why?
|
Focus Groups | 4 | 2021 | 1459 | 0.290 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2419 | 0.280 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2970 | 0.280 |
Why?
|
Minority Groups | 2 | 2022 | 1208 | 0.280 |
Why?
|
Prevalence | 7 | 2024 | 15827 | 0.270 |
Why?
|
Sex Factors | 7 | 2019 | 10614 | 0.270 |
Why?
|
Incidence | 13 | 2021 | 21513 | 0.250 |
Why?
|
Indians, North American | 3 | 2021 | 354 | 0.250 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8038 | 0.250 |
Why?
|
Streptolysins | 4 | 2011 | 61 | 0.250 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14747 | 0.240 |
Why?
|
Cardiovascular Diseases | 5 | 2021 | 15647 | 0.230 |
Why?
|
Risk Assessment | 9 | 2021 | 24276 | 0.230 |
Why?
|
South Carolina | 1 | 2024 | 113 | 0.230 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2040 | 0.230 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2015 | 1378 | 0.230 |
Why?
|
Community-Acquired Infections | 2 | 2011 | 470 | 0.210 |
Why?
|
Pilot Projects | 3 | 2024 | 8724 | 0.210 |
Why?
|
Pericarditis | 1 | 2024 | 135 | 0.200 |
Why?
|
Health Policy | 1 | 2014 | 2700 | 0.200 |
Why?
|
Papillomavirus Infections | 1 | 2014 | 1637 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2249 | 0.190 |
Why?
|
Haiti | 1 | 2024 | 553 | 0.190 |
Why?
|
Insurance | 1 | 2023 | 115 | 0.190 |
Why?
|
Patient Preference | 2 | 2024 | 947 | 0.190 |
Why?
|
Research Design | 2 | 2019 | 6206 | 0.190 |
Why?
|
Health Status | 1 | 2014 | 4086 | 0.190 |
Why?
|
Proportional Hazards Models | 9 | 2021 | 12529 | 0.190 |
Why?
|
Nurses | 2 | 2021 | 2503 | 0.180 |
Why?
|
Habits | 1 | 2021 | 147 | 0.180 |
Why?
|
Cohort Studies | 13 | 2021 | 41684 | 0.170 |
Why?
|
Chronic Disease | 3 | 2021 | 9354 | 0.170 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15882 | 0.170 |
Why?
|
Pain | 1 | 2015 | 5090 | 0.170 |
Why?
|
Trust | 2 | 2021 | 532 | 0.160 |
Why?
|
Current Procedural Terminology | 1 | 2019 | 101 | 0.160 |
Why?
|
Databases, Factual | 4 | 2019 | 8062 | 0.160 |
Why?
|
Community-Based Participatory Research | 1 | 2021 | 223 | 0.160 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2022 | 4627 | 0.160 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 340 | 0.150 |
Why?
|
Oximetry | 1 | 2021 | 461 | 0.150 |
Why?
|
Leukotriene B4 | 3 | 2011 | 281 | 0.150 |
Why?
|
Comorbidity | 3 | 2022 | 10579 | 0.150 |
Why?
|
Registries | 5 | 2024 | 8347 | 0.150 |
Why?
|
Prednisone | 1 | 2022 | 1566 | 0.150 |
Why?
|
Climate Change | 1 | 2024 | 509 | 0.140 |
Why?
|
Renal Artery | 1 | 2019 | 355 | 0.140 |
Why?
|
Geographic Information Systems | 1 | 2019 | 281 | 0.140 |
Why?
|
Delivery of Health Care | 2 | 2014 | 5367 | 0.140 |
Why?
|
Kidney Tubules | 1 | 2019 | 453 | 0.140 |
Why?
|
Documentation | 1 | 2023 | 911 | 0.140 |
Why?
|
Rural Population | 2 | 2020 | 2318 | 0.130 |
Why?
|
Delphi Technique | 1 | 2021 | 893 | 0.130 |
Why?
|
Prospective Studies | 7 | 2024 | 54812 | 0.130 |
Why?
|
New York City | 4 | 2023 | 736 | 0.130 |
Why?
|
Time Factors | 5 | 2021 | 40108 | 0.130 |
Why?
|
Patients | 1 | 2022 | 908 | 0.130 |
Why?
|
Chemokines | 1 | 2020 | 959 | 0.130 |
Why?
|
Public Opinion | 1 | 2019 | 483 | 0.130 |
Why?
|
Cultural Diversity | 3 | 2024 | 370 | 0.120 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 5 | 2010 | 218 | 0.120 |
Why?
|
Cause of Death | 4 | 2021 | 3715 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2024 | 65219 | 0.110 |
Why?
|
Electronic Health Records | 2 | 2024 | 4863 | 0.110 |
Why?
|
Poisson Distribution | 1 | 2015 | 507 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1318 | 0.110 |
Why?
|
Prenatal Care | 1 | 2021 | 1158 | 0.110 |
Why?
|
Sex Distribution | 2 | 2022 | 2270 | 0.110 |
Why?
|
Pregnancy | 4 | 2024 | 30233 | 0.110 |
Why?
|
Eye Diseases | 1 | 2018 | 660 | 0.100 |
Why?
|
Drug Prescriptions | 2 | 2019 | 1662 | 0.100 |
Why?
|
Pamphlets | 1 | 2012 | 71 | 0.100 |
Why?
|
Impetigo | 1 | 2012 | 7 | 0.100 |
Why?
|
Age Distribution | 2 | 2013 | 2865 | 0.100 |
Why?
|
Age Factors | 6 | 2015 | 18386 | 0.100 |
Why?
|
Cross Infection | 1 | 2001 | 1427 | 0.100 |
Why?
|
Mental Health Services | 1 | 2024 | 1729 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2024 | 81565 | 0.100 |
Why?
|
Personal Autonomy | 1 | 2014 | 316 | 0.100 |
Why?
|
Population Surveillance | 2 | 2019 | 2596 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12061 | 0.100 |
Why?
|
Women's Health | 1 | 2021 | 2081 | 0.100 |
Why?
|
Lung Diseases, Obstructive | 1 | 1993 | 309 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2040 | 0.100 |
Why?
|
Social Environment | 2 | 2014 | 1010 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 2019 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1447 | 0.090 |
Why?
|
Self-Help Groups | 1 | 2012 | 194 | 0.090 |
Why?
|
Community-Institutional Relations | 1 | 2012 | 209 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 2271 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5889 | 0.090 |
Why?
|
Self Efficacy | 1 | 2014 | 641 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2969 | 0.090 |
Why?
|
Air Pollution | 1 | 2024 | 2380 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4016 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2662 | 0.090 |
Why?
|
Leadership | 1 | 2019 | 1394 | 0.090 |
Why?
|
Smoking | 3 | 2022 | 9082 | 0.080 |
Why?
|
Child, Preschool | 6 | 2022 | 42511 | 0.080 |
Why?
|
Alcohol Drinking | 2 | 2020 | 4044 | 0.080 |
Why?
|
Pneumonia | 1 | 2001 | 2159 | 0.080 |
Why?
|
Ethanolamines | 1 | 2010 | 152 | 0.080 |
Why?
|
Natural Language Processing | 1 | 2019 | 1198 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 2 | 2024 | 1805 | 0.080 |
Why?
|
Leukotriene Antagonists | 1 | 2010 | 124 | 0.080 |
Why?
|
Social Isolation | 1 | 2012 | 366 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3432 | 0.080 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2010 | 109 | 0.080 |
Why?
|
Environmental Exposure | 1 | 2024 | 4544 | 0.080 |
Why?
|
Inflammation | 4 | 2022 | 10860 | 0.080 |
Why?
|
Mental Health | 2 | 2014 | 3273 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2184 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7871 | 0.080 |
Why?
|
Child Health Services | 1 | 2014 | 645 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2024 | 3274 | 0.080 |
Why?
|
Maternal Health Services | 1 | 2014 | 473 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 873 | 0.080 |
Why?
|
Telephone | 1 | 2012 | 627 | 0.080 |
Why?
|
Health Surveys | 1 | 2019 | 4058 | 0.080 |
Why?
|
Acetates | 1 | 2010 | 314 | 0.080 |
Why?
|
Mass Screening | 1 | 2024 | 5450 | 0.080 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 636 | 0.070 |
Why?
|
India | 1 | 2014 | 2334 | 0.070 |
Why?
|
Zinc | 1 | 2012 | 675 | 0.070 |
Why?
|
Stroke | 3 | 2021 | 9748 | 0.070 |
Why?
|
Retina | 1 | 2018 | 2646 | 0.070 |
Why?
|
Lipids | 1 | 2019 | 3316 | 0.070 |
Why?
|
Child | 9 | 2023 | 80573 | 0.070 |
Why?
|
Community Health Services | 1 | 2012 | 657 | 0.070 |
Why?
|
Superoxides | 4 | 2010 | 382 | 0.070 |
Why?
|
Risk | 3 | 2020 | 9599 | 0.070 |
Why?
|
Health Promotion | 1 | 2019 | 2209 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6768 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 12827 | 0.070 |
Why?
|
Cell Membrane | 1 | 1996 | 3635 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2510 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 453 | 0.070 |
Why?
|
Peer Group | 1 | 2012 | 702 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3784 | 0.070 |
Why?
|
Calcium | 4 | 2011 | 5770 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8725 | 0.060 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2013 | 1374 | 0.060 |
Why?
|
Cytokines | 1 | 2020 | 7426 | 0.060 |
Why?
|
Hodgkin Disease | 1 | 2013 | 1383 | 0.060 |
Why?
|
Antioxidants | 1 | 2013 | 1671 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3270 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13273 | 0.060 |
Why?
|
Counseling | 1 | 2012 | 1553 | 0.060 |
Why?
|
Quinolines | 1 | 2010 | 769 | 0.060 |
Why?
|
Patient Education as Topic | 2 | 2012 | 2332 | 0.060 |
Why?
|
Pain Measurement | 1 | 2015 | 3576 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1248 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2177 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3318 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1890 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3249 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2013 | 1592 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14645 | 0.050 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1463 | 0.050 |
Why?
|
Health Behavior | 1 | 2014 | 2649 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3836 | 0.050 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 164 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2000 | 7474 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2014 | 7843 | 0.050 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 115 | 0.050 |
Why?
|
Insurance, Health | 1 | 2013 | 2520 | 0.050 |
Why?
|
Spiramycin | 1 | 2000 | 3 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 1993 | 4556 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5185 | 0.040 |
Why?
|
Emotions | 1 | 2012 | 2758 | 0.040 |
Why?
|
Clarithromycin | 2 | 2000 | 87 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11509 | 0.040 |
Why?
|
Methotrexate | 2 | 2020 | 1719 | 0.040 |
Why?
|
Bacterial Proteins | 4 | 2011 | 3830 | 0.040 |
Why?
|
Multi-Institutional Systems | 1 | 2019 | 43 | 0.040 |
Why?
|
Pigments, Biological | 1 | 1999 | 52 | 0.040 |
Why?
|
Cities | 1 | 2022 | 542 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1542 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 452 | 0.040 |
Why?
|
Pleurisy | 1 | 2019 | 54 | 0.040 |
Why?
|
Phenazines | 1 | 1999 | 53 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 578 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8616 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2012 | 3427 | 0.040 |
Why?
|
Erythrocyte Membrane | 1 | 2000 | 428 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4306 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8230 | 0.040 |
Why?
|
Heart Failure | 2 | 2021 | 11837 | 0.040 |
Why?
|
Docosahexaenoic Acids | 1 | 2005 | 916 | 0.040 |
Why?
|
Dinoprostone | 1 | 2001 | 593 | 0.040 |
Why?
|
Clinical Coding | 1 | 2019 | 187 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Osteonecrosis | 1 | 2019 | 230 | 0.040 |
Why?
|
Fluid Therapy | 1 | 2001 | 587 | 0.040 |
Why?
|
Social Stigma | 1 | 2024 | 787 | 0.040 |
Why?
|
Long-Term Care | 1 | 2001 | 630 | 0.040 |
Why?
|
Roxithromycin | 1 | 1996 | 3 | 0.040 |
Why?
|
Hospital Information Systems | 1 | 2019 | 395 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 1999 | 573 | 0.030 |
Why?
|
Calcimycin | 1 | 1996 | 214 | 0.030 |
Why?
|
Ionophores | 1 | 1996 | 108 | 0.030 |
Why?
|
Erythromycin | 1 | 1996 | 114 | 0.030 |
Why?
|
Zymosan | 1 | 1996 | 133 | 0.030 |
Why?
|
Lysophosphatidylcholines | 1 | 1996 | 77 | 0.030 |
Why?
|
Platelet Activating Factor | 1 | 1996 | 142 | 0.030 |
Why?
|
Respiratory Burst | 1 | 1996 | 107 | 0.030 |
Why?
|
NF-kappa B | 1 | 2005 | 2495 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2019 | 344 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2741 | 0.030 |
Why?
|
Morbidity | 1 | 2001 | 1753 | 0.030 |
Why?
|
Pancreatic Elastase | 2 | 2010 | 124 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1181 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1870 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 822 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1596 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22228 | 0.030 |
Why?
|
Azithromycin | 1 | 1996 | 202 | 0.030 |
Why?
|
Causality | 1 | 2001 | 1247 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 1996 | 341 | 0.030 |
Why?
|
Contraceptives, Oral | 1 | 2017 | 559 | 0.030 |
Why?
|
Infection Control | 1 | 2001 | 984 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2353 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29912 | 0.030 |
Why?
|
Atrophy | 1 | 2019 | 1629 | 0.030 |
Why?
|
Primary Prevention | 1 | 2001 | 1187 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2426 | 0.030 |
Why?
|
Diet | 1 | 2012 | 8087 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1973 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2023 | 1804 | 0.030 |
Why?
|
Pneumonia, Viral | 1 | 2011 | 3233 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39243 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2114 | 0.030 |
Why?
|
Survival Analysis | 2 | 2015 | 10087 | 0.030 |
Why?
|
Asthma | 4 | 1996 | 6268 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2188 | 0.020 |
Why?
|
Toxoids | 1 | 2011 | 11 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2073 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2018 | 59515 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2022 | 2689 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 1999 | 1276 | 0.020 |
Why?
|
Cyclic AMP | 2 | 2010 | 1467 | 0.020 |
Why?
|
Anti-Asthmatic Agents | 1 | 1996 | 572 | 0.020 |
Why?
|
Bronchiectasis | 1 | 1993 | 141 | 0.020 |
Why?
|
Obesity | 3 | 2022 | 13085 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2024 | 3077 | 0.020 |
Why?
|
Quality of Life | 1 | 2012 | 13468 | 0.020 |
Why?
|
Hemolysis | 2 | 2005 | 408 | 0.020 |
Why?
|
Cytochalasin B | 1 | 2010 | 74 | 0.020 |
Why?
|
Rolipram | 1 | 2010 | 24 | 0.020 |
Why?
|
Calcium-Transporting ATPases | 2 | 2001 | 122 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5873 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2727 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2911 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2915 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 745 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3853 | 0.020 |
Why?
|
Sulfides | 1 | 2010 | 168 | 0.020 |
Why?
|
Albuterol | 1 | 2010 | 211 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2010 | 436 | 0.020 |
Why?
|
Paternal Behavior | 1 | 1988 | 33 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3798 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6324 | 0.020 |
Why?
|
Length of Stay | 1 | 2001 | 6490 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15403 | 0.020 |
Why?
|
Placebos | 1 | 2012 | 1659 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3769 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2011 | 702 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2901 | 0.020 |
Why?
|
Calcium Channels | 1 | 2010 | 622 | 0.020 |
Why?
|
Antimalarials | 1 | 2013 | 909 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2018 | 3712 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2021 | 4527 | 0.020 |
Why?
|
Drug Interactions | 1 | 2010 | 1419 | 0.020 |
Why?
|
Adenosine Triphosphate | 2 | 2001 | 2003 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2005 | 6493 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 1993 | 1284 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2011 | 18967 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168800 | 0.010 |
Why?
|
Toxoplasmosis | 1 | 1982 | 94 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13616 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2005 | 699 | 0.010 |
Why?
|
Forecasting | 1 | 2011 | 2936 | 0.010 |
Why?
|
Cholelithiasis | 1 | 1983 | 408 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 18076 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5939 | 0.010 |
Why?
|
Phospholipases A2 | 1 | 2001 | 197 | 0.010 |
Why?
|
Phospholipases A | 1 | 2001 | 204 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26290 | 0.010 |
Why?
|
Macrophage-1 Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
Cell Degranulation | 1 | 2001 | 276 | 0.010 |
Why?
|
Body Mass Index | 1 | 2017 | 13046 | 0.010 |
Why?
|
Leukocyte Elastase | 1 | 1999 | 113 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2001 | 479 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12426 | 0.010 |
Why?
|
Social Support | 1 | 1988 | 2190 | 0.010 |
Why?
|
Sheep | 1 | 2000 | 1445 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2001 | 1085 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 484 | 0.010 |
Why?
|
Mothers | 1 | 1988 | 2206 | 0.010 |
Why?
|
Potassium | 1 | 2001 | 1312 | 0.010 |
Why?
|
Pneumococcal Infections | 1 | 2001 | 529 | 0.010 |
Why?
|
Peroxidase | 1 | 1999 | 610 | 0.010 |
Why?
|
Sodium | 1 | 1999 | 1591 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26381 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36427 | 0.010 |
Why?
|
Escherichia coli | 1 | 2001 | 4210 | 0.000 |
Why?
|
Home Nursing | 1 | 1988 | 92 | 0.000 |
Why?
|
Urban Health | 1 | 1986 | 531 | 0.000 |
Why?
|
Jews | 1 | 1983 | 359 | 0.000 |
Why?
|
Health Education | 1 | 1988 | 1060 | 0.000 |
Why?
|
Self Care | 1 | 1986 | 800 | 0.000 |
Why?
|
Serologic Tests | 1 | 1982 | 382 | 0.000 |
Why?
|
Emergencies | 1 | 1986 | 1224 | 0.000 |
Why?
|
Brazil | 1 | 1982 | 1248 | 0.000 |
Why?
|
Body Height | 1 | 1983 | 1561 | 0.000 |
Why?
|
Parents | 1 | 1988 | 3591 | 0.000 |
Why?
|
Cholesterol | 1 | 1983 | 2902 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1986 | 5531 | 0.000 |
Why?
|
Body Weight | 1 | 1983 | 4626 | 0.000 |
Why?
|
Blood Glucose | 1 | 1983 | 6421 | 0.000 |
Why?
|